New York State Common Retirement Fund decreased its position in Helmerich & Payne, Inc. (NYSE:HP – Free Report) by 5.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 739,046 shares of the oil and gas company’s stock after selling 45,337 shares during the quarter. New York State Common Retirement Fund’s holdings in Helmerich & Payne were worth $22,482,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Headlands Technologies LLC bought a new position in Helmerich & Payne in the first quarter worth $33,000. Covestor Ltd raised its holdings in Helmerich & Payne by 253.4% in the first quarter. Covestor Ltd now owns 940 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 674 shares in the last quarter. Whittier Trust Co. raised its holdings in Helmerich & Payne by 94.9% in the first quarter. Whittier Trust Co. now owns 1,222 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 595 shares in the last quarter. Blue Trust Inc. raised its holdings in Helmerich & Payne by 127.8% in the third quarter. Blue Trust Inc. now owns 1,522 shares of the oil and gas company’s stock worth $46,000 after purchasing an additional 854 shares in the last quarter. Finally, Eastern Bank bought a new position in Helmerich & Payne in the third quarter worth $61,000. Institutional investors own 96.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on HP shares. Royal Bank of Canada raised their price target on Helmerich & Payne from $48.00 to $50.00 and gave the company a “sector perform” rating in a report on Friday, July 26th. Evercore ISI upgraded Helmerich & Payne to a “strong-buy” rating in a report on Friday, July 26th. Barclays reduced their price target on Helmerich & Payne from $42.00 to $39.00 and set an “equal weight” rating for the company in a report on Wednesday, October 16th. The Goldman Sachs Group reduced their price target on Helmerich & Payne from $38.00 to $34.00 and set a “sell” rating for the company in a report on Thursday, August 29th. Finally, Piper Sandler reduced their price target on Helmerich & Payne from $39.00 to $36.00 and set a “neutral” rating for the company in a report on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $40.29.
Helmerich & Payne Price Performance
NYSE HP opened at $33.72 on Tuesday. Helmerich & Payne, Inc. has a one year low of $29.46 and a one year high of $44.11. The stock has a 50-day moving average of $32.83 and a 200 day moving average of $35.50. The company has a market capitalization of $3.33 billion, a price-to-earnings ratio of 9.77, a PEG ratio of 3.56 and a beta of 1.40. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.87 and a current ratio of 2.12.
Helmerich & Payne Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 2.97%. Helmerich & Payne’s payout ratio is 28.99%.
Helmerich & Payne Profile
Founded in 1920, Helmerich & Payne, Inc (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders.
Further Reading
- Five stocks we like better than Helmerich & Payne
- The How and Why of Investing in Gold Stocks
- Intel: Is Now the Time to Be Brave?Â
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding HP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helmerich & Payne, Inc. (NYSE:HP – Free Report).
Receive News & Ratings for Helmerich & Payne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helmerich & Payne and related companies with MarketBeat.com's FREE daily email newsletter.